Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ABVE vs MGN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MGN Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–1 Matrix Metrics)

MGN Overall Winner 6-Pillar Tally: ABVE 3 – 3 MGN Matrix Metrics: ABVE 1 – 7 MGN

As of Nov 16, 2026, Megan Holdings Limited (MGN) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas MGN carries 45.2/100 (HOLD) at $3.53 (N/M Forward P/E, -7.8% operating margin).

  • Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile MGN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 56.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ABVE vs MGN
ABVE NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
TTM Revenue $295M
Forward P/E N/M
Beta / 30D Vol 4.10β · 310% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.1%), weak momentum, RSI 28
RSI-14: 28.0 · SMA20: $0.55 · SMA50: $0.67
MGN NASDAQ Head-to-Head Winner
Megan Holdings Limited Ordinary Shares
Agricultural Prod-Livestock & Animal Specialties
$3.53
-1.94% 1D
Market Cap $58.4M
TTM Revenue $83M
Forward P/E N/M
Beta / 30D Vol 21.11β · 158% Vol
Unified Composite Score
45.2 / 100 HOLD
Tech 40.0 Fund 35.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (75.0% over 20 days), RSI 56
RSI-14: 56.2 · SMA20: $3.23 · SMA50: $2.91

6-Pillar Scorecard Institutional Category Breakdown (ABVE 3 – 3 MGN)

Columns: Metric · ABVE · MGN
1. Valuation Multiples ABVE
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.1x 0.7x
2. Growth & Scale MGN
Revenue Growth (YoY) -45.0% -8.4%
Earnings Growth (YoY) +0.0% -31.3%
TTM Revenue (USD) $295M $83M
Market Cap $30.0M $58.4M
3. Profitability & Quality MGN
Gross Margin -2.8% 0.8%
Operating Margin -23.2% -7.8%
Net Profit Margin -23.4% -8.3%
Return on Equity (ROE) 0.0% -12.6%
4. Balance Sheet & Cash Flow MGN
Cash Generation (TTM) -$40M EBITDA -$6.4M EBITDA
Cash Flow Margin -13.7% EBITDA Mgn -7.7% EBITDA Mgn
Net Cash / Leverage 0.0% ROE $14.39 Book/Sh · -12.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABVE
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 148.3% (8th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat ABVE
OpEx & R&D Intensity 20.4% of Rev ($60M) 8.6% of Rev ($7.1M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Engineering & Construction Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ABVE (1) vs MGN (7)
Institutional Metric ABVE MGN Criterion Row Edge
Market Capitalization
Scale
$30.0M $58.4M Larger Scale MGN
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-45.0% -8.4% Higher Growth MGN
Operating Margin (TTM)
Profitability
-23.2% -7.8% Higher Margin MGN
Net Profit Margin
Profitability
-23.4% -8.3% Higher Margin MGN
Return on Equity (ROE)
Capital Efficiency
0.0% -12.6% Higher ROE ABVE
52-Week Range Position
Momentum
0% ($0–$7) 68% ($0–$5) Stronger Trend MGN
Beta / 30D Volatility
Risk Regime
4.10β · 310% Vol 21.11β · 158% Vol Lower Realized Risk MGN
Unified Institutional Score
Composite Signal
39.8 / 100 (SELL) 45.2 / 100 (HOLD) Higher Composite MGN
Trailing 12M Revenue (USD)
Operating Scale
$295M $83M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-2.8% 0.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev N/M PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$40M EBITDA (0.0% ROE) -$6.4M EBITDA ($14.39 Book/Sh · -12.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MGN +65.89 pp
ABVE: -79.18% · MGN: -13.29%
3M Horizon ABVE +2.4 pp
ABVE: -91.43% · MGN: -93.83%
6M Horizon MGN +2.88 pp
ABVE: -95.67% · MGN: -92.79%
1Y Horizon MGN +4.52 pp
ABVE: -95.7% · MGN: -91.18%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs MGN. Trailing 12-month operating profitability (ABVE -23.2% vs MGN -7.8%) and valuation multiples (ABVE N/M vs MGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ABVE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$295M
Gross Margin-2.8%
Op. Margin-23.2%
ROE / Fwd P/E0.0% · N/M
MGN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$83M
Gross Margin0.8%
Op. Margin-7.8%
ROE / Fwd P/E-12.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ABVE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 148.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ABVE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MGN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MGN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ABVE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment 20.4% of Rev ($60M)
90D Engineering Disclosures 0 Published
MGN Moat Profile Cyclical / Execution-Driven Positioning
Engineering & Construction Operator
Competes within the Engineering & Construction value chain with $58.4M market capitalization and -7.8% operating margin.
OpEx & R&D Reinvestment 8.6% of Rev ($7.1M)
90D Engineering Disclosures 0 Published

Investor FAQ ABVE vs MGN Key Questions & Quantitative Answers

As of Nov 16, 2026, Megan Holdings Limited (MGN) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas MGN carries 45.2/100 (HOLD) at $3.53 (N/M Forward P/E, -7.8% operating margin). Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile MGN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 56.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MGN leads the Growth & Scale pillar: ABVE posts -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin), compared with MGN at -8.4% YoY revenue growth and -31.3% YoY earnings growth on $83M TTM revenue (0.8% gross margin, -7.8% operating margin). On trailing 12-month operating scale, ABVE generates $295M in USD-normalized revenue versus $83M for MGN. In operating R&D and SG&A reinvestment, ABVE deploys 20.4% of Rev ($60M) (0 90-day corporate R&D disclosures) versus 8.6% of Rev ($7.1M) (0 disclosures) for MGN.

ABVE screens cheaper on headline valuation multiples. ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin), whereas MGN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-7.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVE (0.0% ROE) versus MGN (-12.6% ROE) capital efficiency.

In options market volatility and institutional positioning, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk). By comparison, MGN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (21.11β · 158% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.